Aspect Biosystems CEO Tamer Mohamed will be presenting at the annual Cell & Gene Meeting on the Med to be held April 15-17, 2025 in Rome, Italy at the Rome Cavalieri and livestreamed globally. Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Med is Europe's premier conference for advanced therapies featuring over 50 dedicated company presentations by leading public and private companies, as well as expert-led panels and featured speakers.
The following are specific details regarding Aspect Biosystems’ presentation and panel:
| Aspect Biosystems Company Presentation | |
| Date | Wednesday, April 16, 2025 |
| Time | 5:00pm CEST |
| Location | Salone dei Cavalieri, Section 2
|
Panel - Tissue Therapeutics: The Promise of Rationally Designed Tissues to Replace Lost Function | |
| Date | Tuesday, April 15, 2025 |
| Time | 5:15pm CEST |
| Location | Salone dei Cavalieri, Section 3&4
|
Virtual attendance is available which includes a livestream and the ability to view all conference sessions on-demand. Please visit meetingonthemed.com for full information.
About Aspect Biosystems
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials. Aspect is advancing a pipeline of bioprinted tissue therapeutics across multiple disease areas in the endocrine and metabolic space including diabetes, obesity, rare endocrine disorders, and liver disease. Aspect's pipeline development strategy involves both proprietary programs as well as strategic partnerships, including a collaboration with Novo Nordisk focused on diabetes and obesity. For more information, please visit www.aspectbiosystems.com and follow on LinkedIn.
Contact
Natalie Korenic
Aspect Biosystems
media@aspectbiosystems.com